CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-03 | Lennon David James CHIEF EXECUTIVE OFFICER | Sale | −9,689 | $1.94 | $19K | 22,869 |
| 2024-10-02 | Lennon David James CHIEF EXECUTIVE OFFICER | Option exercise | +32,558 | 32,558 | ||
| 2024-10-02 | Lennon David James CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −32,558 | 0 | ||
| 2024-09-03 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −40,000 | $1.71 | $68K | 1,171,543 |
| 2024-08-05 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −5,652 | $1.34 | $8K | 1,211,543 |
| 2024-08-02 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −18,933 | $1.41 | $27K | 1,217,195 |
| 2024-08-01 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −15,415 | $1.50 | $23K | 1,236,128 |
| 2024-07-02 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −8,652 | $1.34 | $12K | 1,251,543 |
| 2024-07-01 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −31,348 | $1.45 | $46K | 1,260,195 |
| 2024-06-12 | Aghazadeh Behzad Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-12 | Maroun Richard E Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-12 | Hirmand Mohammad Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-12 | Reeve Emma Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-12 | Castelein Caley Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-12 | Dalal Anupam Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-12 | Hehenberger Karin M. Director | Grant or award · Stock Option (right to buy) | +45,832 | 45,832 | ||
| 2024-06-04 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −20,225 | $1.77 | $36K | 1,291,543 |
| 2024-06-03 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −19,775 | $1.81 | $36K | 1,311,768 |
| 2024-05-01 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −40,000 | $1.93 | $77K | 1,331,543 |
| 2024-04-02 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −22,228 | $2.23 | $50K | 1,371,543 |
Page 6 of 9 · 171 trades